Gi Insights

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Douglas K. Rex, MD Millions of colonoscopies are performed each year in the United States, but which indicators should we be using to measure the quality of these procedures? Dr. Peter Buch is joined by Dr. Douglas Rex, Distinguished Professor Emeritus of Medicine at Indiana University School of Medicine, to discuss the importance of these indicators.

Host: Neilanjan Nandi, MD Guest: Folasade P. May, MD, PhD, MPhil Racial and ethnic bias prevent patients with colorectal cancer from receiving the highest quality of care. Dr. Neil Nandi is joined by Dr. Fola May, Assistant Professor of Medicine at UCLA, to discuss racial inequalities in access to care and screening for patients with colorectal cancer.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Nicole Hanley-Williams, MD The management of motility disorders like achalasia and gastroparesis can be very complex for both patients and clinicians alike. Fortunately, there have been several advancements in the evaluation and treatment of these disorders. Joining Dr. Peter Buch to walk us through what those developments are and how they can help improve our patients’ quality of life is Dr. Nicole Hanley-Williams, who specializes in motility and functional disorders at Beth Israel Lahey Health.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Philip Ginsburg, MD Tofacitinib is a common treatment option for patients with ulcerative colitis. But it’s not without its risks. Here to share what we need to consider before we start our patients on tofacitinib is Dr. Philip Ginsburg, Medical Director of Research and the Director of the Inflammatory Bowel Disease Center of Connecticut.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Philip Ginsburg, MD With so many treatment options currently available for moderate to severe Crohn’s disease and ulcerative colitis, how do you know which one will work best for your patients? Joining Dr. Peter Buch to help answer that and other questions is Dr. Philip Ginsburg, Medical Director of Research and the Director of the Inflammatory Bowel Disease Center of Connecticut.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Jeffrey Basile, MD Now that we have therapies like vedolizumab and ustekinumab, many are wondering if there’s still a role for anti-TNFs in the treatment of IBD. Here to share his perspective and how he uses the multitude of available treatment options to his advantage is Dr. Jeffrey Basile, a gastroenterologist from Charleston GI.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Jeffrey Basile, MD The treatment and evaluation of inflammatory bowel disease, or IBD, is continuously changing to provide the best quality of care for patients. Dr. Peter Buch is joined by Dr. Jeffrey Basile, a gastroenterologist from Charleston GI, to shed some light on the latest treatment options for IBD patients.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Paul Feuerstadt MD, FACG, AGAF Clostridium difficile impacts many patients around the United States. How can we better diagnose and treat this infection? Dr. Peter Buch is joined by Dr. Paul Feuerstadt, Assistant Clinical Professor of Medicine at Yale New Haven Hospital the discuss the importance of managing Clostridium difficile.

Host: Neilanjan Nandi, MD Guest: Brian E. Lacy, MD, PhD What do we need to know about choosing the right medication for our patients with IBS? Stay tuned as Dr. Neil Nandi talks with Dr. Brain Lacy, a gastroenterologist at the Mayo Clinic, Jacksonville, and the co-editor-in-chief of the American Journal of Gastroenterology, on these pharmacologic therapies.

Host: Neilanjan Nandi, MD Guest: Brian E. Lacy, MD, PhD Irritable bowel syndrome can be difficult to manage for both physicians and patients. What can we do to help better diagnose and manage IBS? Here today is Dr. Neil Nandi who is discussing the IBS Guidelines highlights with Dr. Brain Lacy, a gastroenterologist at the Mayo Clinic, Jacksonville, Florida, and the co-editor-in-chief of the American Journal of Gastroenterology.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Ronnie Fass, MD Non-cardiac chest pain, NCCP, is chest pain in patients who do not have heart disease. How do we identify and diagnose NCCP? Stay tuned as Dr. Peter Buch talks with Dr. Ronnie Fass, Chief of the Division of Gastroenterology and Hepatology, on the important aspects of non-cardiac chest pain.

Host: Neilanjan Nandi, MD Guest: Tiffany H. Taft, PsyD Avoidant Restrictive Food Intake Disorder, AFRID, is a newly introduced eating disorder at the forefront of GI care. Stay tuned to hear Dr. Neil Nandi discuss the impact of ARFID on GI health with Dr. Tiffany Taft, the Director of Psychogastroenterology Research in the Division of Gastroenterology and Hepatology at Northwestern University.

Host: Neilanjan Nandi, MD Guest: Tiffany H. Taft, PsyD Patients with an inflammatory bowel disorder, or IBD, often suffer from post-traumatic stress disorder, or PTSD. But how do the psychological impacts of PTSD impact our IBD patients? Dr. Neil Nandi is joined by Dr. Tiffany Taft, the Director of Psychogastroenterology Research in the Division of Gastroenterology and Hepatology at Northwestern University, to discuss IBD’s relationship with PTSD.

Host: Neilanjan Nandi, MD Guest: Maria T. Abreu, MD Environmental factors can affect many different aspects of a patient’s heath, but how do these factors play a role in developing inflammatory bowel disorders, or IBD? Tune in to hear Dr. Neil Nandi and Dr. Maria Abreu, the director of the Crohn’s and Colitis Center at the University of Miami, discuss the role of environmental factors in patients at risk of developing IBD.

Host: Neilanjan Nandi, MD Guest: Maria T. Abreu, MD Diet is a common concern for many patients with inflammatory bowel disorders. How can we best guide our patients on the influence of diet? Dr. Neil Nandi is joined by Dr. Maria Abreu, the director of the Crohn’s and Colitis Center at the University of Miami, to discuss the impact of diet on ulcerative colitis.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Joseph C. Anderson, MD Colon cancer rates for patients younger than 50 have increased at an alarming rate. How can we help screen our younger individuals for colon cancer? Tune in to hear Dr. Peter Buch speak with Dr. Joseph Anderson, Associate Professor of Medicine at Dartmouth, to discuss the transitions occurring in colon cancer screening.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Douglas Drossman, MD Guest: Johannah Ruddy, MEd A strong doctor-physician partnership is a critical component of patient care. Here today is Dr. Peter Buch who will be joined by Dr. Douglas Drossman, President of the Rome Foundation, and Ms. Johanna Ruddy, Executive Director of the Rome Foundation, to discuss how to build this foundation and maintain the relationship.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Myron Brand, MD While many know that COVID-19 can affect the respiratory system, but how can this disease also influence the gastrointestinal tract? Tune in to hear Dr. Peter Buch discuss with Dr. Myron Brand, a Clinical Professor of Medicine, Yale University School of Medicine, the impact of COVID-19 on the GI system and GI disorders.

Host: Peter Buch, MD, FACG, AGAF, FACP While diverticulitis is a common disease, what can be done to help better understand this infection? Here today is our GI Insights host, Dr. Peter Buch, to discuss complications and approaches to managing and treating diverticulitis.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Devika Umashanker, MD Obesity is a worldwide phenomenon and linked to morbidity and mortality. How can we help our obese patients along their weight loss journey to ensure long-term success? Dr. Peter Buch is joined by Dr. Devika Umashanker, Obesity Medicine Director of the Department of Bariatric Surgery at Hartford HealthCare Medical Group, to assess strategies for helping your patients see positive long-term weight loss outcomes.